Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global market for Biodegradable Implantable Drug Delivery System was estimated to be worth US$ 1286 million in 2024 and is forecast to a readjusted size of US$ 1923 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
A biodegradable implantable drug delivery system is a medical device or drug delivery system that is made of biodegradable materials and can be implanted into the human or animal body for sustained release of drugs or therapeutic substances, and then gradually decomposes into biodegradable materials. Absorbed components that are ultimately completely metabolized or eliminated by the organism
Biodegradable Implantable Drug Delivery System Market Size(US$)
M= millions and B=billions

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Biodegradable Implantable Drug Delivery System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Biodegradable Implantable Drug Delivery System by region & country, by Type, and by Application.
The Biodegradable Implantable Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biodegradable Implantable Drug Delivery System.
Market Segmentation
Report Metric
Details
Report Title
Biodegradable Implantable Drug Delivery System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Forecasted Market Size in 2031
US$ 1923 million
CAGR(2025-2031)
6%
Market Size Available for Years
2025-2031
Global Biodegradable Implantable Drug Delivery System Companies Covered
Abbive
TerSera Therapeutics
Azurity
Simcere
Intersect ENT
Clinuvel
Innocoll Biotherapeutics
Global Biodegradable Implantable Drug Delivery System Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biodegradable Implantable Drug Delivery System Market, Segment by Type
Subcutaneous Implant Type
Injection Implant Type
Other
Global Biodegradable Implantable Drug Delivery System Market, Segment by Application
Tumor
Ophthalmology
Other
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biodegradable Implantable Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Biodegradable Implantable Drug Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Biodegradable Implantable Drug Delivery System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Biodegradable Implantable Drug Delivery System Product Introduction
1.2 Global Biodegradable Implantable Drug Delivery System Market Size Forecast
1.2.1 Global Biodegradable Implantable Drug Delivery System Sales Value (2020-2031)
1.2.2 Global Biodegradable Implantable Drug Delivery System Sales Volume (2020-2031)
1.2.3 Global Biodegradable Implantable Drug Delivery System Sales Price (2020-2031)
1.3 Biodegradable Implantable Drug Delivery System Market Trends & Drivers
1.3.1 Biodegradable Implantable Drug Delivery System Industry Trends
1.3.2 Biodegradable Implantable Drug Delivery System Market Drivers & Opportunity
1.3.3 Biodegradable Implantable Drug Delivery System Market Challenges
1.3.4 Biodegradable Implantable Drug Delivery System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biodegradable Implantable Drug Delivery System Players Revenue Ranking (2024)
2.2 Global Biodegradable Implantable Drug Delivery System Revenue by Company (2020-2025)
2.3 Global Biodegradable Implantable Drug Delivery System Players Sales Volume Ranking (2024)
2.4 Global Biodegradable Implantable Drug Delivery System Sales Volume by Company Players (2020-2025)
2.5 Global Biodegradable Implantable Drug Delivery System Average Price by Company (2020-2025)
2.6 Key Manufacturers Biodegradable Implantable Drug Delivery System Manufacturing Base and Headquarters
2.7 Key Manufacturers Biodegradable Implantable Drug Delivery System Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Biodegradable Implantable Drug Delivery System
2.9 Biodegradable Implantable Drug Delivery System Market Competitive Analysis
2.9.1 Biodegradable Implantable Drug Delivery System Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Biodegradable Implantable Drug Delivery System Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodegradable Implantable Drug Delivery System as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Subcutaneous Implant Type
3.1.2 Injection Implant Type
3.1.3 Other
3.2 Global Biodegradable Implantable Drug Delivery System Sales Value by Type
3.2.1 Global Biodegradable Implantable Drug Delivery System Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Biodegradable Implantable Drug Delivery System Sales Value, by Type (2020-2031)
3.2.3 Global Biodegradable Implantable Drug Delivery System Sales Value, by Type (%) (2020-2031)
3.3 Global Biodegradable Implantable Drug Delivery System Sales Volume by Type
3.3.1 Global Biodegradable Implantable Drug Delivery System Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Biodegradable Implantable Drug Delivery System Sales Volume, by Type (2020-2031)
3.3.3 Global Biodegradable Implantable Drug Delivery System Sales Volume, by Type (%) (2020-2031)
3.4 Global Biodegradable Implantable Drug Delivery System Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tumor
4.1.2 Ophthalmology
4.1.3 Other
4.2 Global Biodegradable Implantable Drug Delivery System Sales Value by Application
4.2.1 Global Biodegradable Implantable Drug Delivery System Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Biodegradable Implantable Drug Delivery System Sales Value, by Application (2020-2031)
4.2.3 Global Biodegradable Implantable Drug Delivery System Sales Value, by Application (%) (2020-2031)
4.3 Global Biodegradable Implantable Drug Delivery System Sales Volume by Application
4.3.1 Global Biodegradable Implantable Drug Delivery System Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Biodegradable Implantable Drug Delivery System Sales Volume, by Application (2020-2031)
4.3.3 Global Biodegradable Implantable Drug Delivery System Sales Volume, by Application (%) (2020-2031)
4.4 Global Biodegradable Implantable Drug Delivery System Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Biodegradable Implantable Drug Delivery System Sales Value by Region
5.1.1 Global Biodegradable Implantable Drug Delivery System Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Biodegradable Implantable Drug Delivery System Sales Value by Region (2020-2025)
5.1.3 Global Biodegradable Implantable Drug Delivery System Sales Value by Region (2026-2031)
5.1.4 Global Biodegradable Implantable Drug Delivery System Sales Value by Region (%), (2020-2031)
5.2 Global Biodegradable Implantable Drug Delivery System Sales Volume by Region
5.2.1 Global Biodegradable Implantable Drug Delivery System Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Biodegradable Implantable Drug Delivery System Sales Volume by Region (2020-2025)
5.2.3 Global Biodegradable Implantable Drug Delivery System Sales Volume by Region (2026-2031)
5.2.4 Global Biodegradable Implantable Drug Delivery System Sales Volume by Region (%), (2020-2031)
5.3 Global Biodegradable Implantable Drug Delivery System Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Biodegradable Implantable Drug Delivery System Sales Value, 2020-2031
5.4.2 North America Biodegradable Implantable Drug Delivery System Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Biodegradable Implantable Drug Delivery System Sales Value, 2020-2031
5.5.2 Europe Biodegradable Implantable Drug Delivery System Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Biodegradable Implantable Drug Delivery System Sales Value, 2020-2031
5.6.2 Asia Pacific Biodegradable Implantable Drug Delivery System Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Biodegradable Implantable Drug Delivery System Sales Value, 2020-2031
5.7.2 South America Biodegradable Implantable Drug Delivery System Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Biodegradable Implantable Drug Delivery System Sales Value, 2020-2031
5.8.2 Middle East & Africa Biodegradable Implantable Drug Delivery System Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biodegradable Implantable Drug Delivery System Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Biodegradable Implantable Drug Delivery System Sales Value
6.2.1 Key Countries/Regions Biodegradable Implantable Drug Delivery System Sales Value, 2020-2031
6.2.2 Key Countries/Regions Biodegradable Implantable Drug Delivery System Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Biodegradable Implantable Drug Delivery System Sales Value, 2020-2031
6.3.2 United States Biodegradable Implantable Drug Delivery System Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Biodegradable Implantable Drug Delivery System Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Biodegradable Implantable Drug Delivery System Sales Value, 2020-2031
6.4.2 Europe Biodegradable Implantable Drug Delivery System Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Biodegradable Implantable Drug Delivery System Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Biodegradable Implantable Drug Delivery System Sales Value, 2020-2031
6.5.2 China Biodegradable Implantable Drug Delivery System Sales Value by Type (%), 2024 VS 2031
6.5.3 China Biodegradable Implantable Drug Delivery System Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Biodegradable Implantable Drug Delivery System Sales Value, 2020-2031
6.6.2 Japan Biodegradable Implantable Drug Delivery System Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Biodegradable Implantable Drug Delivery System Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Biodegradable Implantable Drug Delivery System Sales Value, 2020-2031
6.7.2 South Korea Biodegradable Implantable Drug Delivery System Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Biodegradable Implantable Drug Delivery System Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Biodegradable Implantable Drug Delivery System Sales Value, 2020-2031
6.8.2 Southeast Asia Biodegradable Implantable Drug Delivery System Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Biodegradable Implantable Drug Delivery System Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Biodegradable Implantable Drug Delivery System Sales Value, 2020-2031
6.9.2 India Biodegradable Implantable Drug Delivery System Sales Value by Type (%), 2024 VS 2031
6.9.3 India Biodegradable Implantable Drug Delivery System Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Abbive
7.1.1 Abbive Company Information
7.1.2 Abbive Introduction and Business Overview
7.1.3 Abbive Biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Abbive Biodegradable Implantable Drug Delivery System Product Offerings
7.1.5 Abbive Recent Development
7.2 TerSera Therapeutics
7.2.1 TerSera Therapeutics Company Information
7.2.2 TerSera Therapeutics Introduction and Business Overview
7.2.3 TerSera Therapeutics Biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 TerSera Therapeutics Biodegradable Implantable Drug Delivery System Product Offerings
7.2.5 TerSera Therapeutics Recent Development
7.3 Azurity
7.3.1 Azurity Company Information
7.3.2 Azurity Introduction and Business Overview
7.3.3 Azurity Biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Azurity Biodegradable Implantable Drug Delivery System Product Offerings
7.3.5 Azurity Recent Development
7.4 Simcere
7.4.1 Simcere Company Information
7.4.2 Simcere Introduction and Business Overview
7.4.3 Simcere Biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Simcere Biodegradable Implantable Drug Delivery System Product Offerings
7.4.5 Simcere Recent Development
7.5 Intersect ENT
7.5.1 Intersect ENT Company Information
7.5.2 Intersect ENT Introduction and Business Overview
7.5.3 Intersect ENT Biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Intersect ENT Biodegradable Implantable Drug Delivery System Product Offerings
7.5.5 Intersect ENT Recent Development
7.6 Clinuvel
7.6.1 Clinuvel Company Information
7.6.2 Clinuvel Introduction and Business Overview
7.6.3 Clinuvel Biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Clinuvel Biodegradable Implantable Drug Delivery System Product Offerings
7.6.5 Clinuvel Recent Development
7.7 Innocoll Biotherapeutics
7.7.1 Innocoll Biotherapeutics Company Information
7.7.2 Innocoll Biotherapeutics Introduction and Business Overview
7.7.3 Innocoll Biotherapeutics Biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Innocoll Biotherapeutics Biodegradable Implantable Drug Delivery System Product Offerings
7.7.5 Innocoll Biotherapeutics Recent Development
8 Industry Chain Analysis
8.1 Biodegradable Implantable Drug Delivery System Industrial Chain
8.2 Biodegradable Implantable Drug Delivery System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biodegradable Implantable Drug Delivery System Sales Model
8.5.2 Sales Channel
8.5.3 Biodegradable Implantable Drug Delivery System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Biodegradable Implantable Drug Delivery System Market Trends
Table 2. Biodegradable Implantable Drug Delivery System Market Drivers & Opportunity
Table 3. Biodegradable Implantable Drug Delivery System Market Challenges
Table 4. Biodegradable Implantable Drug Delivery System Market Restraints
Table 5. Global Biodegradable Implantable Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Biodegradable Implantable Drug Delivery System Revenue Market Share by Company (2020-2025)
Table 7. Global Biodegradable Implantable Drug Delivery System Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Biodegradable Implantable Drug Delivery System Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Biodegradable Implantable Drug Delivery System Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Biodegradable Implantable Drug Delivery System Manufacturing Base and Headquarters
Table 11. Key Manufacturers Biodegradable Implantable Drug Delivery System Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Biodegradable Implantable Drug Delivery System
Table 13. Global Biodegradable Implantable Drug Delivery System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodegradable Implantable Drug Delivery System as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Biodegradable Implantable Drug Delivery System Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Biodegradable Implantable Drug Delivery System Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Biodegradable Implantable Drug Delivery System Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Biodegradable Implantable Drug Delivery System Sales Market Share in Value by Type (2020-2025)
Table 20. Global Biodegradable Implantable Drug Delivery System Sales Market Share in Value by Type (2026-2031)
Table 21. Global Biodegradable Implantable Drug Delivery System Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Biodegradable Implantable Drug Delivery System Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Biodegradable Implantable Drug Delivery System Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Biodegradable Implantable Drug Delivery System Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Biodegradable Implantable Drug Delivery System Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Biodegradable Implantable Drug Delivery System Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Biodegradable Implantable Drug Delivery System Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Biodegradable Implantable Drug Delivery System Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Biodegradable Implantable Drug Delivery System Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Biodegradable Implantable Drug Delivery System Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Biodegradable Implantable Drug Delivery System Sales Market Share in Value by Application (2020-2025)
Table 32. Global Biodegradable Implantable Drug Delivery System Sales Market Share in Value by Application (2026-2031)
Table 33. Global Biodegradable Implantable Drug Delivery System Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Biodegradable Implantable Drug Delivery System Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Biodegradable Implantable Drug Delivery System Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Biodegradable Implantable Drug Delivery System Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Biodegradable Implantable Drug Delivery System Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Biodegradable Implantable Drug Delivery System Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Biodegradable Implantable Drug Delivery System Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Biodegradable Implantable Drug Delivery System Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Biodegradable Implantable Drug Delivery System Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Biodegradable Implantable Drug Delivery System Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Biodegradable Implantable Drug Delivery System Sales Value by Region (2020-2025) & (%)
Table 44. Global Biodegradable Implantable Drug Delivery System Sales Value by Region (2026-2031) & (%)
Table 45. Global Biodegradable Implantable Drug Delivery System Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Biodegradable Implantable Drug Delivery System Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Biodegradable Implantable Drug Delivery System Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Biodegradable Implantable Drug Delivery System Sales Volume by Region (2020-2025) & (%)
Table 49. Global Biodegradable Implantable Drug Delivery System Sales Volume by Region (2026-2031) & (%)
Table 50. Global Biodegradable Implantable Drug Delivery System Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Biodegradable Implantable Drug Delivery System Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Biodegradable Implantable Drug Delivery System Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Biodegradable Implantable Drug Delivery System Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Biodegradable Implantable Drug Delivery System Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Biodegradable Implantable Drug Delivery System Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Biodegradable Implantable Drug Delivery System Sales Volume, (2026-2031) & (K Units)
Table 57. Abbive Company Information
Table 58. Abbive Introduction and Business Overview
Table 59. Abbive Biodegradable Implantable Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Abbive Biodegradable Implantable Drug Delivery System Product Offerings
Table 61. Abbive Recent Development
Table 62. TerSera Therapeutics Company Information
Table 63. TerSera Therapeutics Introduction and Business Overview
Table 64. TerSera Therapeutics Biodegradable Implantable Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. TerSera Therapeutics Biodegradable Implantable Drug Delivery System Product Offerings
Table 66. TerSera Therapeutics Recent Development
Table 67. Azurity Company Information
Table 68. Azurity Introduction and Business Overview
Table 69. Azurity Biodegradable Implantable Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Azurity Biodegradable Implantable Drug Delivery System Product Offerings
Table 71. Azurity Recent Development
Table 72. Simcere Company Information
Table 73. Simcere Introduction and Business Overview
Table 74. Simcere Biodegradable Implantable Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Simcere Biodegradable Implantable Drug Delivery System Product Offerings
Table 76. Simcere Recent Development
Table 77. Intersect ENT Company Information
Table 78. Intersect ENT Introduction and Business Overview
Table 79. Intersect ENT Biodegradable Implantable Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Intersect ENT Biodegradable Implantable Drug Delivery System Product Offerings
Table 81. Intersect ENT Recent Development
Table 82. Clinuvel Company Information
Table 83. Clinuvel Introduction and Business Overview
Table 84. Clinuvel Biodegradable Implantable Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Clinuvel Biodegradable Implantable Drug Delivery System Product Offerings
Table 86. Clinuvel Recent Development
Table 87. Innocoll Biotherapeutics Company Information
Table 88. Innocoll Biotherapeutics Introduction and Business Overview
Table 89. Innocoll Biotherapeutics Biodegradable Implantable Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Innocoll Biotherapeutics Biodegradable Implantable Drug Delivery System Product Offerings
Table 91. Innocoll Biotherapeutics Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Biodegradable Implantable Drug Delivery System Downstream Customers
Table 95. Biodegradable Implantable Drug Delivery System Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Biodegradable Implantable Drug Delivery System Product Picture
Figure 2. Global Biodegradable Implantable Drug Delivery System Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Biodegradable Implantable Drug Delivery System Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Biodegradable Implantable Drug Delivery System Sales Volume (2020-2031) & (K Units)
Figure 5. Global Biodegradable Implantable Drug Delivery System Sales Price (2020-2031) & (US$/Unit)
Figure 6. Biodegradable Implantable Drug Delivery System Report Years Considered
Figure 7. Global Biodegradable Implantable Drug Delivery System Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Biodegradable Implantable Drug Delivery System Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Biodegradable Implantable Drug Delivery System Revenue in 2024
Figure 10. Biodegradable Implantable Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Subcutaneous Implant Type Picture
Figure 12. Injection Implant Type Picture
Figure 13. Other Picture
Figure 14. Global Biodegradable Implantable Drug Delivery System Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Biodegradable Implantable Drug Delivery System Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Biodegradable Implantable Drug Delivery System Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 17. Global Biodegradable Implantable Drug Delivery System Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Biodegradable Implantable Drug Delivery System Price by Type (2020-2031) & (US$/Unit)
Figure 19. Product Picture of Tumor
Figure 20. Product Picture of Ophthalmology
Figure 21. Product Picture of Other
Figure 22. Global Biodegradable Implantable Drug Delivery System Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Biodegradable Implantable Drug Delivery System Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Biodegradable Implantable Drug Delivery System Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 25. Global Biodegradable Implantable Drug Delivery System Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Biodegradable Implantable Drug Delivery System Price by Application (2020-2031) & (US$/Unit)
Figure 27. North America Biodegradable Implantable Drug Delivery System Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Biodegradable Implantable Drug Delivery System Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Biodegradable Implantable Drug Delivery System Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Biodegradable Implantable Drug Delivery System Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Biodegradable Implantable Drug Delivery System Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Biodegradable Implantable Drug Delivery System Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Biodegradable Implantable Drug Delivery System Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Biodegradable Implantable Drug Delivery System Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Biodegradable Implantable Drug Delivery System Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Biodegradable Implantable Drug Delivery System Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Biodegradable Implantable Drug Delivery System Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Biodegradable Implantable Drug Delivery System Sales Volume (%), (2020-2031)
Figure 39. United States Biodegradable Implantable Drug Delivery System Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Biodegradable Implantable Drug Delivery System Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Biodegradable Implantable Drug Delivery System Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Biodegradable Implantable Drug Delivery System Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Biodegradable Implantable Drug Delivery System Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Biodegradable Implantable Drug Delivery System Sales Value by Application (%), 2024 VS 2031
Figure 45. China Biodegradable Implantable Drug Delivery System Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Biodegradable Implantable Drug Delivery System Sales Value by Type (%), 2024 VS 2031
Figure 47. China Biodegradable Implantable Drug Delivery System Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Biodegradable Implantable Drug Delivery System Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Biodegradable Implantable Drug Delivery System Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Biodegradable Implantable Drug Delivery System Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Biodegradable Implantable Drug Delivery System Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Biodegradable Implantable Drug Delivery System Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Biodegradable Implantable Drug Delivery System Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Biodegradable Implantable Drug Delivery System Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Biodegradable Implantable Drug Delivery System Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Biodegradable Implantable Drug Delivery System Sales Value by Application (%), 2024 VS 2031
Figure 57. India Biodegradable Implantable Drug Delivery System Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Biodegradable Implantable Drug Delivery System Sales Value by Type (%), 2024 VS 2031
Figure 59. India Biodegradable Implantable Drug Delivery System Sales Value by Application (%), 2024 VS 2031
Figure 60. Biodegradable Implantable Drug Delivery System Industrial Chain
Figure 61. Biodegradable Implantable Drug Delivery System Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives InterviewedDescription
The global market for Biodegradable Implantable Drug Delivery System was estimated to be worth US$ 1286 million in 2024 and is forecast to a readjusted size of US$ 1923 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
A biodegradable implantable drug delivery system is a medical device or drug delivery system that is made of biodegradable materials and can be implanted into the human or animal body for sustained release of drugs or therapeutic substances, and then gradually decomposes into biodegradable materials. Absorbed components that are ultimately completely metabolized or eliminated by the organism
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Biodegradable Implantable Drug Delivery System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Biodegradable Implantable Drug Delivery System by region & country, by Type, and by Application.
The Biodegradable Implantable Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biodegradable Implantable Drug Delivery System.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biodegradable Implantable Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Biodegradable Implantable Drug Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Biodegradable Implantable Drug Delivery System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Related Reports
A biodegradable implantable drug delivery system is a medical device or drug delivery system that is made of biodegradable materials and can be implanted into the human or animal body for sustained release of drugs or therapeutic substances, and then gradually decomposes into biodegradable materials. Absorbed components that are ultimately completely metabolized or eliminated by the organism
Published: 2024-01-17
Pages: 85
USD 2900.00
(Single User License)
A biodegradable implantable drug delivery system is a medical device or drug delivery system that is made of biodegradable materials and can be implanted into the human or animal body for sustained release of drugs or therapeutic substances, and then gradually decomposes into biodegradable materials. Absorbed components that are ultimately completely metabolized or eliminated by the organism
Published: 2024-04-26
Pages: 88
USD 4900.00
(Single User License)
The global market for Biodegradable Implantable Drug Delivery System was valued at US$ 1286 million in the year 2024 and is projected to reach a revised size of US$ 1923 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published: 2025-02-14
Pages: 82
USD 2900.00
(Single User License)
The global Biodegradable Implantable Drug Delivery System market size was US$ 1286 million in 2024 and is forecast to a readjusted size of US$ 1923 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 78
USD 4250.00
(Single User License)
The global Biodegradable Implantable Drug Delivery System market is projected to grow from US$ 1286 million in 2024 to US$ 1923 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 144
USD 4900.00
(Single User License)
The global Biodegradable Implantable Drug Delivery System market was valued at US$ 1355 million in 2025 and is anticipated to reach US$ 2026 million by 2032, at a CAGR of 6.0% from 2026 to 2032.
Published: 2026-02-11
Pages: 116
USD 2900.00
(Single User License)
The global market for Biodegradable Implantable Drug Delivery System was estimated to be worth US$ 1355 million in 2025 and is projected to reach US$ 2026 million, growing at a CAGR of 6.0% from 2026 to 2032.
Published: 2026-02-11
Pages: 94
USD 3950.00
(Single User License)
A biodegradable implantable drug delivery system is a medical device or drug delivery system that is made of biodegradable materials and can be implanted into the human or animal body for sustained release of drugs or therapeutic substances, and then gradually decomposes into biodegradable materials. Absorbed components that are ultimately completely metabolized or eliminated by the organism
Published: 2024-01-17
Pages: 85
A biodegradable implantable drug delivery system is a medical device or drug delivery system that is made of biodegradable materials and can be implanted into the human or animal body for sustained release of drugs or therapeutic substances, and then gradually decomposes into biodegradable materials. Absorbed components that are ultimately completely metabolized or eliminated by the organism
Published: 2024-04-26
Pages: 88
The global market for Biodegradable Implantable Drug Delivery System was valued at US$ 1286 million in the year 2024 and is projected to reach a revised size of US$ 1923 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published: 2025-02-14
Pages: 82
The global Biodegradable Implantable Drug Delivery System market size was US$ 1286 million in 2024 and is forecast to a readjusted size of US$ 1923 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 78
The global Biodegradable Implantable Drug Delivery System market is projected to grow from US$ 1286 million in 2024 to US$ 1923 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 144
The global Biodegradable Implantable Drug Delivery System market was valued at US$ 1355 million in 2025 and is anticipated to reach US$ 2026 million by 2032, at a CAGR of 6.0% from 2026 to 2032.
Published: 2026-02-11
Pages: 116
The global market for Biodegradable Implantable Drug Delivery System was estimated to be worth US$ 1355 million in 2025 and is projected to reach US$ 2026 million, growing at a CAGR of 6.0% from 2026 to 2032.
Published: 2026-02-11
Pages: 94
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database